Bowel Incontinence Clinical Trials

Find Bowel Incontinence Clinical Trials Near You

Autologous Muscle Fiber Fragment Injections for the Treatment of Fecal Incontinence

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To regenerate functional anal sphincter muscle using muscle fiber fragments that contain muscle precursor cells (MPCs)

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 18 years of age

• participants must experience 4 or more Fecal Incontinence (FI) episodes per 2 week period

• participants must score \>10 on Cleveland Clinic Fecal Incontinence Severity Scoring System (CCIS)

• participants must have had symptoms for at least 12 months

• participants who have failed standard medical and surgical treatments for FI

• participant will undergo anorectal manometry (ARM) testing

• participants will undergo endoscopic anal ultrasound and demonstrate an anatomic defect of the anal sphincter complex of at least 30 degrees

• women of childbearing potential must use acceptable contraceptives during this study

Locations
United States
North Carolina
Wake Forest University Health Sciences
RECRUITING
Winston-salem
Contact Information
Primary
Mary-Clare Day, RN, BSN
Maryclare.Day@advocatehealth.org
336.713.1343
Time Frame
Start Date: 2023-01-12
Estimated Completion Date: 2029-12
Participants
Target number of participants: 10
Treatments
Experimental: Muscle Fiber Fragment (MFF) injections
autologous muscle fiber fragment injections, harvested in an autologous fashion from the quadriceps muscle, for the treatment of Fecal Incontinence (FI) symptoms in men and women with a demonstrated anal sphincter defect and who have failed conservative treatments
Related Therapeutic Areas
Sponsors
Leads: Wake Forest University Health Sciences

This content was sourced from clinicaltrials.gov